Compare LPA & BTMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LPA | BTMD |
|---|---|---|
| Founded | 2013 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.2M | 80.4M |
| IPO Year | N/A | N/A |
| Metric | LPA | BTMD |
|---|---|---|
| Price | $2.60 | $2.44 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 29.3K | ★ 130.7K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 270.48 |
| EPS | 0.21 | ★ 0.78 |
| Revenue | $47,536,343.00 | ★ $195,645,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.80 |
| P/E Ratio | $12.44 | ★ $3.17 |
| Revenue Growth | ★ 7.28 | 1.34 |
| 52 Week Low | $2.55 | $2.32 |
| 52 Week High | $11.16 | $6.36 |
| Indicator | LPA | BTMD |
|---|---|---|
| Relative Strength Index (RSI) | 35.71 | 38.59 |
| Support Level | $2.65 | $2.56 |
| Resistance Level | $2.94 | $2.80 |
| Average True Range (ATR) | 0.17 | 0.14 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 2.38 | 1.14 |
Logistic Properties of the Americas is a fully-integrated, internally managed real estate company that develops, owns, and manages a diversified portfolio of warehouse logistics assets in Central America and South America. It focuses on modern Class A logistics real estate in high-growth and high-barrier-to-entry markets that are undersupplied and have low penetration rates. The company has three operating segments, based on geographic regions, consisting of Colombia, Peru, and Costa Rica. The company generates the majority of its revenue from the Costa Rica geographical segment.
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company derives revenue from United States and also has its presence in other countries.